Furthermore, PEG3 mutation was significantly associated with high TMB and inferior prognosis, and the associations were independent of multiple confounding factors including age, tumor stage and mutations of BRCA1, BRCA2 and POLE. The gene discussed is BRCA2; the disease is neoplasm.